Literature DB >> 30116852

[Update of the German S3 guideline on atraumatic femoral head necrosis in adults].

Andreas Roth1, Johannes Beckmann2, Klaus Bohndorf3, Christian Heiß4, Marcus Jäger5, Stefan Landgraeber5, Uwe Maus6, Ulrich Nöth7, Klaus M Peters8, Christof Rader9, Stephan Reppenhagen10, Ulrich Smolenski11, Ina Kopp12, Markus Tingart13.   

Abstract

The update of the German S3 guideline on atraumatic femoral head necrosis in adults aims to provide an overview of diagnosis and treatment. All clinical studies, systematic reviews, and meta-analyses published in German or English between 01.05.2013 and 30.04.2017 were included. Of 427 studies, 28 were suitable for analysis. Risk factors are corticosteroids, chemotherapy, kidney transplants, hemoglobinopathies, and alcoholism. Differential diagnoses are for example bone marrow edema, insufficiency fracture, and destructive arthropathy. Radiography should be performed upon clinical suspicion. In patients with normal radiography findings but persistent complaints, magnetic resonance imaging (ARCO classification) is the method of choice. Computed tomography (CT) can be used to confirm/exclude articular surface collapse. A subchondral sclerosis zone >30% in CT indicates a better prognosis. Left untreated, a subchondral fracture will develop within 2 years. The risk of disease development in the opposite side is high during the first 2 years, but unlikely thereafter. In conservative therapy, iloprost and alendronate can be used in a curative approach, the latter for small, primarily medial necrosis. Conservative therapy alone as well as other drug-based and physical approaches are not suitable for treatment. No particular joint-preserving surgery can currently be recommended. Core decompression should be performed in early stages with <30% necrosis. From ARCO stage IIIc or in stage IV, the indication for total hip arthroplasty should be checked. Results after total hip arthroplasty are comparable with those after coxarthrosis, although the revision rate is higher due to the relatively young age of patients. Statements on the effectiveness of cell-based therapies such as expanded stem cells or bone marrow aspirates cannot currently be made.

Entities:  

Keywords:  Bisphosphonates; Bone transplantation; Iloprost; Surgical decompression; Total joint replacement

Mesh:

Year:  2018        PMID: 30116852     DOI: 10.1007/s00132-018-3620-x

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  37 in total

Review 1.  [S3 Guideline. Part 1: Diagnosis and Differential Diagnosis of Non-Traumatic Adult Femoral Head Necrosis].

Authors:  K Bohndorf; J Beckmann; M Jäger; W Kenn; U Maus; U Nöth; K M Peters; C Rader; S Reppenhagen; A Roth
Journal:  Z Orthop Unfall       Date:  2015-08-14       Impact factor: 0.923

2.  Free vascularized fibular grafting for patients receiving postoperative corticosteroids.

Authors:  Hao Ding; Sheng-Bao Chen; You-Shui Gao; Sen Lin; Chang-Qing Zhang
Journal:  Orthopedics       Date:  2014-04       Impact factor: 1.390

3.  Arthroplasty in patients with extensive femoral head avascular necrosis: Cementless arthroplasty in extensive femoral head necrosis.

Authors:  Yu-Hang Gao; Shu-Qiang Li; Yun-Feng Wang; Chen Yang; Jian-Guo Liu; Xin Qi
Journal:  Int Orthop       Date:  2015-02-18       Impact factor: 3.075

4.  Combination treatment of biomechanical support and targeted intra-arterial infusion of peripheral blood stem cells mobilized by granulocyte-colony stimulating factor for the osteonecrosis of the femoral head: a randomized controlled clinical trial.

Authors:  Qiang Mao; Weidong Wang; Taotao Xu; Shanxing Zhang; Luwei Xiao; Di Chen; Hongting Jin; Peijian Tong
Journal:  J Bone Miner Res       Date:  2015-04       Impact factor: 6.741

Review 5.  Short-stem hip arthroplasty in osteonecrosis of the femoral head.

Authors:  Thilo Floerkemeier; Stefan Budde; Jens Gronewold; Kerstin Radtke; Max Ettinger; Henning Windhagen; Gabriela von Lewinski
Journal:  Arch Orthop Trauma Surg       Date:  2015-03-24       Impact factor: 3.067

6.  Does the extent of osteonecrosis affect the survival of hip resurfacing?

Authors:  Satoshi Nakasone; Masaki Takao; Takashi Sakai; Takashi Nishii; Nobuhiko Sugano
Journal:  Clin Orthop Relat Res       Date:  2013-02-09       Impact factor: 4.176

7.  [S3 Guideline. Part 3: Non-Traumatic Avascular Necrosis in Adults - Surgical Treatment of Atraumatic Avascular Femoral Head Necrosis in Adults].

Authors:  U Maus; A Roth; M Tingart; C Rader; M Jäger; U Nöth; S Reppenhagen; C Heiss; J Beckmann
Journal:  Z Orthop Unfall       Date:  2015-08-05       Impact factor: 0.923

8.  S3-Guideline non-traumatic adult femoral head necrosis.

Authors:  A Roth; J Beckmann; K Bohndorf; A Fischer; C Heiß; W Kenn; M Jäger; U Maus; U Nöth; K M Peters; C Rader; S Reppenhagen; U Smolenski; M Tingart; I Kopp; I Sirotin; S J Breusch
Journal:  Arch Orthop Trauma Surg       Date:  2015-12-14       Impact factor: 3.067

9.  Increased risk of revision in patients with non-traumatic femoral head necrosis.

Authors:  Camilla Bergh; Ann M Fenstad; Ove Furnes; Göran Garellick; Leif I Havelin; Søren Overgaard; Alma B Pedersen; Keijo T Mäkelä; Pekka Pulkkinen; Maziar Mohaddes; Johan Kärrholm
Journal:  Acta Orthop       Date:  2013-12-20       Impact factor: 3.717

10.  Long-term Clinical Results after Iloprost Treatment for Bone Marrow Edema and Avascular Necrosis.

Authors:  Tim Claßen; Antonia Becker; Stefan Landgraeber; Marcel Haversath; Xinning Li; Christoph Zilkens; Rüdiger Krauspe; Marcus Jäger
Journal:  Orthop Rev (Pavia)       Date:  2016-03-31
View more
  4 in total

Review 1.  [Drug treatment of osteonecrosis].

Authors:  Andreas Roth; Uwe Maus
Journal:  Orthopadie (Heidelb)       Date:  2022-09-08

Review 2.  Computer assistance in hip preservation surgery-current status and introduction of our system.

Authors:  Klemen Stražar
Journal:  Int Orthop       Date:  2020-09-11       Impact factor: 3.075

Review 3.  Efficacy and safety of stem cell therapy for the early-stage osteonecrosis of femoral head: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Lianghao Mao; Pan Jiang; Xuan Lei; Chenlie Ni; Yiming Zhang; Bing Zhang; Qiping Zheng; Dapeng Li
Journal:  Stem Cell Res Ther       Date:  2020-10-19       Impact factor: 6.832

Review 4.  Treatment of non-traumatic avascular necrosis of the femoral head (Review).

Authors:  Ning Liu; Changming Zheng; Qinglong Wang; Zhipeng Huang
Journal:  Exp Ther Med       Date:  2022-03-10       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.